Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical Characteristics of Hospitalized COVID-19 Patients Who Received at Least One Dose of COVID-19 Vaccine
Piotr Rzymski, Monika Pazgan−Simon, Krzysztof Simon, et al.
Vaccines (2021) Vol. 9, Iss. 7, pp. 781-781
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
Piotr Rzymski, Barbara Poniedziałek, Andrzej Fal
Vaccines (2021) Vol. 9, Iss. 11, pp. 1286-1286
Open Access | Times Cited: 148
COVID-19 Vaccine Boosters: The Good, the Bad, and the Ugly
Piotr Rzymski, Carlos A. Camargo, Andrzej Fal, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1299-1299
Open Access | Times Cited: 76
Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19
Bindu Adhikari, Joseph S. Bednash, Jeffrey C. Horowitz, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Autopsy Findings and Causality Relationship between Death and COVID-19 Vaccination: A Systematic Review
Francesco Sessa, Monica Salerno, Massimiliano Esposito, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 24, pp. 5876-5876
Open Access | Times Cited: 52
Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of February 23, 2022
Robert Flisiak, Andrzej Horban, Jerzy Jaroszewicz, et al.
Polskie Archiwum Medycyny Wewnętrznej (2022) Vol. 132, Iss. 3
Open Access | Times Cited: 28
Associations of vaccine status with characteristics and outcomes of hospitalized severe COVID-19 patients in the booster era
Ophir Freund, Luba Tau, Tali Weiss, et al.
PLoS ONE (2022) Vol. 17, Iss. 5, pp. e0268050-e0268050
Open Access | Times Cited: 28
COVID-19 Vaccination and Rates of Infections, Hospitalizations, ICU Admissions, and Deaths in the European Economic Area during Autumn 2021 Wave of SARS-CoV-2
Dominika Sikora, Piotr Rzymski
Vaccines (2022) Vol. 10, Iss. 3, pp. 437-437
Open Access | Times Cited: 27
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1112-1178
Closed Access | Times Cited: 6
The association of airborne particulate matter and benzo[a]pyrene with the clinical course of COVID-19 in patients hospitalized in Poland
Piotr Rzymski, Barbara Poniedziałek, Joanna Rosińska, et al.
Environmental Pollution (2022) Vol. 306, pp. 119469-119469
Open Access | Times Cited: 25
COVID‐19 vaccines reduce mortality in hospitalized patients with oxygen requirements: Differences between vaccine subtypes. A multicontinental cohort study
Iván Huespe, Augusto Ferraris, Antonio Lalueza, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 5
Open Access | Times Cited: 12
Differences in the Evolution of Clinical, Biochemical, and Hematological Indicators in Hospitalized Patients with COVID-19 According to Their Vaccination Scheme: A Cohort Study in One of the World’s Highest Hospital Mortality Populations
Martha A. Mendoza-Hernandez, José Guzmán-Esquivel, Marco A. Ramos-Rojas, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 72-72
Open Access | Times Cited: 4
COVID-19 Breakthrough Infections and Transmission Risk: Real-World Data Analyses from Germany’s Largest Public Health Department (Cologne)
Lea Hsu, Barbara Grüne, Michael Buess, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1267-1267
Open Access | Times Cited: 29
Demographic and Clinical Overview of Hospitalized COVID-19 Patients during the First 17 Months of the Pandemic in Poland
Robert Flisiak, Piotr Rzymski, Dorota Zarębska‐Michaluk, et al.
Journal of Clinical Medicine (2021) Vol. 11, Iss. 1, pp. 117-117
Open Access | Times Cited: 27
Attitudes toward Receiving COVID-19 Booster Dose in the Middle East and North Africa (MENA) Region: A Cross-Sectional Study of 3041 Fully Vaccinated Participants
Mohamed Abouzid, Alhassan Ali Ahmed, Dina M. El‐Sherif, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1270-1270
Open Access | Times Cited: 20
Does Hospitalization Change the Perception of COVID-19 Vaccines among Unvaccinated Patients?
Dorota Zarębska‐Michaluk, Piotr Rzymski, Anna Moniuszko‐Malinowska, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 476-476
Open Access | Times Cited: 19
Severe Breakthrough COVID-19 Cases during Six Months of Delta Variant (B.1.617.2) Domination in Poland
Piotr Rzymski, Monika Pazgan−Simon, Juliusz Kamerys, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 557-557
Open Access | Times Cited: 19
Clinical characteristics and outcomes of critically ill patients with one, two and three doses of vaccination against COVID‐19 in Australia
Madeleine Otto, Aidan Burrell, Ary Serpa Neto, et al.
Internal Medicine Journal (2022) Vol. 53, Iss. 3, pp. 330-338
Open Access | Times Cited: 16
Comparison of severity of immunized versus non-immunized COVID-19 patients admitted to ICU: A prospective observational study
Huda Mhawish, Ahmed Mady, Faisal Alaklobi, et al.
Annals of Medicine and Surgery (2021) Vol. 71, pp. 102951-102951
Open Access | Times Cited: 22
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1275-1344
Open Access | Times Cited: 2
The Severity of COVID 19 Pneumonia in Vaccinated vs. Non-vaccinated Patients in the Second Wave: An Experience From a Tertiary Care Center in India
Jyoti Bajpai, Surya Kant, Ajay Verma, et al.
Cureus (2022)
Open Access | Times Cited: 9
Efficacy and Safety of Sitagliptin in the Treatment of COVID-19
Ehab Mudher Mikhael, Siew Chin Ong, Siti Maisharah Sheikh Ghadzi
Journal of Pharmacy Practice (2022) Vol. 36, Iss. 4, pp. 980-987
Open Access | Times Cited: 8
Short‐term exposure to ambient air pollution and COVID‐19 severity during SARS‐CoV‐2 Delta and Omicron waves: A multicenter study
Barbara Poniedziałek, Piotr Rzymski, Dorota Zarębska‐Michaluk, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 7
Closed Access | Times Cited: 4
Effect of COVID-19 on Anti-S Antibody Response in Healthcare Workers Six Months Post-Vaccination
Robert Flisiak, Małgorzata Pawłowska, Magdalena Rogalska, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1325-1325
Open Access | Times Cited: 11
The Effect of Reduced Oxygen Saturation on Retinal Microvascularization in COVID-19 Patients with Bilateral Pneumonia Based on Optical Coherence Tomography Study
Magdalena Kal, Mateusz Winiarczyk, Jerzy Mackiewicz, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 11, pp. 1824-1824
Open Access | Times Cited: 7
Comparison of the Clinical and Laboratory Findings and Outcomes of Hospitalized COVID-19 Patients Who Were Either Fully Vaccinated with Coronavac or Not: An Analytical, Cross Sectional Study
Serap Şimşek Yavuz, Gülşah Tunçer, Özlem Altuntaş Aydın, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 733-733
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top